These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37170593)

  • 1. Neuropsychiatric features of Parkinson's disease in the era prior to the use of dopaminergic therapies.
    Zhang C; Reeves S; David AS; Costello H; Rogers J
    Cogn Neuropsychiatry; 2023 Jul; 28(4):243-252. PubMed ID: 37170593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
    Williams-Gray CH; Foltynie T; Lewis SJ; Barker RA
    CNS Drugs; 2006; 20(6):477-505. PubMed ID: 16734499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinations and the spectrum of psychosis in Parkinson's disease.
    Frei K; Truong DD
    J Neurol Sci; 2017 Mar; 374():56-62. PubMed ID: 28108020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropsychiatry of Parkinson's disease and related disorders.
    Lauterbach EC
    Psychiatr Clin North Am; 2004 Dec; 27(4):801-25. PubMed ID: 15550293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Cannabis on hallucinations in Parkinson's disease patients.
    Cravanas B; Frei K
    J Neurol Sci; 2020 Dec; 419():117206. PubMed ID: 33161300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
    Lee AH; Weintraub D
    Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence, associated factors and phenomenology of psychosis in patients with Parkinson's disease].
    Rodríguez-Violante M; Velázquez-Osuna S; Cervantes-Arriaga A; Corona-Vázquez T; de la Fuente-Sandoval C
    Gac Med Mex; 2015; 151(2):169-75. PubMed ID: 25946527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinson's disease as a neuropsychiatric disorder].
    Sommer IE; van Laar T
    Ned Tijdschr Geneeskd; 2019 Aug; 163():. PubMed ID: 31386313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Characteristics of Psychosis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Chendo I; Silva C; Duarte GS; Prada L; Voon V; Ferreira JJ
    J Parkinsons Dis; 2022; 12(1):85-94. PubMed ID: 34806620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucinations and psychosis in Parkinson's disease.
    Rabey JM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric Issues in Parkinson's Disease.
    Cooney JW; Stacy M
    Curr Neurol Neurosci Rep; 2016 May; 16(5):49. PubMed ID: 27048443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.
    Rojas M; Chávez-Castillo M; Duran P; Ortega Á; Bautista-Sandoval MJ; Salazar J; Riaño-Garzón M; Chacín M; Medina-Ortiz O; Palmar J; Cudris-Torres L; Bermúdez V
    Curr Pharm Des; 2022; 28(33):2725-2741. PubMed ID: 36321314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.
    Schrag A; Horsfall L; Walters K; Noyce A; Petersen I
    Lancet Neurol; 2015 Jan; 14(1):57-64. PubMed ID: 25435387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms.
    Meng D; Jin Z; Wang Y; Fang B
    CNS Neurosci Ther; 2023 Aug; 29(8):2259-2266. PubMed ID: 36924300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
    Bailbé M; Karolewicz S; Neau JP; Dumas P; Gil R;
    Rev Neurol (Paris); 2002 Feb; 158(2):203-10. PubMed ID: 11965176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.